Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Pharma Industry News Marksans Pharma’s Relonchem wins UK MHRA approval for Loperamide 2 mg capsules Marksans Pharma’s Relonchem secures UK MHRA nod for Loperamide 2 mg capsules, boosting its UK market reach with Goa-made generics. bySrinathDecember 12, 2021